Ventracor Limited (ASX: VCR) Announce 150 VentrAssist Implants Worldwide
Sydney, Oct 5, 2007 (ABN Newswire) - Ventracor (ASX: VCR) today announced the 150th implant of the VentrAssist Left Ventricular Assist Device (LVAD). Ventracor also reports 11 patients have been enrolled in the US Bridge To Transplant (BTT) Pivotal Trial and four enrolled in the US Destination Therapy (DT) Trial.